NCT06308289Completed
Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD
Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique on Cardiorespiratory Fitness, Posture and Quality of Life in Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 23 Jul 2024
Brief summary (registry, in English)
The randomized controlled trial will involve 30 participants, with Group A receiving GPRM and ACBT, while Group B follows the conventional COPD model that includes ACBT only.Assessments of heart rate, physical fitness, and quality of life will contribute to a nuanced understanding of joint function, informing future COPD treatment paradigms.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 68 (actual)
- First submitted
- 4 Mar 2024
- Start date
- 3 Mar 2024
- Primary completion date
- 5 Jun 2024
- Lead sponsor
- Riphah International University
- Diseases
- COPD
- NCT number
- NCT06308289
What you commit to
- Study type: Interventional
- Participants enrolled: 68
- From 3 Mar 2024 to the primary completion date, 5 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals who have undergone major thoracic or abdominal surgery within the past three months
Other illness
- Participants with severe comorbidities, such as unstable cardiovascular diseases (e.g., recent myocardial infarction, uncontrolled hypertension)
- Participants diagnosed with respiratory conditions other than COPD (such as asthma, interstitial lung disease)
- Individuals with severe mental health conditions (such as uncontrolled psychosis or severe depression)
Other
- Acute Exacerbation of COPD
- Pregnant or lactating individuals.
Who the study is looking for
- Adults aged 40-75 years diagnosed with stable COPD (according to GOLD guidelines).
- Patients of both genders
- FEV1: FVC ranging from 68 - 69%.
- Predicted FEV1 of less than 70%.
- Willingness to participate
Age in the registry: 40 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Social Security Hospital Coordinator of this site? Confirm its status | Gujranwala | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.